AFT Pharmaceuticals: FY21 Result — Pain Relieving
AFT PharmaceuticalsFY21 Result — Pain Relieving RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) reported an FY21 result at the upper-end of its...
620 Views
AFT Pharmaceuticals - Growth in the face of a challenging environment
AFT Pharmaceuticals recently reported its results for FY21. Operating revenue grew strongly by 7% year-on-year to NZ$113.1m, driven mainly by 11%...
537 Views
AFT Pharmaceuticals: On Script With a New Deal
AFT PharmaceuticalsOn Script With a New Deal RESEARCH INSIGHTS AFT has ticked off another milestone with the signing of an agreement for...
375 Views
AFT Pharmaceuticals: Guidance Lowered; COVID Side Effects Linger
AFT PharmaceuticalsGuidance Lowered; COVID Side Effects Linger RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) materially downgraded its FY21 EBIT...
616 Views
AFT Pharmaceuticals: 1H21 Result —Under the Weather
AFT Pharmaceuticals1H21 Result —Under the Weather RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) reported 1H21 underlying growth of ~+9%, albeit...
564 Views